Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14)

Table 5 Effect of clustering of components of Metabolic Syndrome on microangiopathies

		Prevalence of Microangiopathies
Components of MS		Diabetic Retinopathy			Diabetic Nephropathy			Diabetic Neuropathy
	N	n	%	Trend p	n	%	Trend p	n	%	Trend p
Overall (n = 1043)
+ Any one	309	39	12.6	0.193	43	13.9	0.013	65	21.2	0.929
+Any two	448	90	20.1		83	18.5		75	16.8
+ Any three	286	47	16.4		62	21.7		61	21.6
Men (n = 490)
+ Any one	171	30	17.5	0.779	27	15.8	0.945	46	26.9	0.077
+Any two	193	44	22.8		34	17.6		33	17.1
+ Any three	126	23	18.3		20	15.9		24	19.2
Women (n = 553)
+ Any one	138	9	6.5	0.049	16	11.6	0.001	19	14.0	0.030
+Any two	255	46	18.0		49	19.2		42	16.6
+ Any three	160	24	15.0		42	26.3		37	23.6

MS, Metabolic Syndrome; MS absent, Diabetes only or Diabetes + Obesity; + Any one, Diabetes + Obesity + Any of hypertension, reduced HDL or elevated triglyceride; + Any two, Diabetes + Obesity + Any two of hypertension, reduced HDL or elevated triglyceride; + Any three, Diabetes + Obesity + All three of hypertension, reduced HDL or elevated triglyceride; N, Total population with metabolic syndrome; n, Population with metabolic syndrome having microangiopathies

ISSN: 1758-5996